Who can have abiraterone?
Abiraterone is suitable for men with advanced prostate cancer that has stopped responding to other hormone therapy and chemotherapy, such as docetaxel. Abiraterone is available for these men on the NHS.
But if you’ve already had enzalutamide as well as chemotherapy, abiraterone is not widely available.
- In England, you won’t be able to have abiraterone if you’ve already had enzalutamide – unless you had to stop taking enzalutamide within three months because of severe side effects or because your cancer continued to grow.
- In Wales, you won’t be able to have abiraterone if you've already had enzalutamide.
- In Scotland and Northern Ireland, if you've already had enzalutamide, you should speak to your doctor about whether abiraterone is available for you.
Abiraterone is also effective in men who have stopped responding to hormone therapy but haven't yet had chemotherapy. It is licensed for these men in the UK, but it’s not widely available on the NHS in England, Wales and Northern ireland. This is because the National Institute for Health and Care Excellence (NICE) hasn't recommended it for these men. But if your doctor thinks it’s suitable for you, they may be able to apply for you to get it. If you live in Scotland, abiraterone is available to you if you haven't had chemotherapy. Read more about getting new treatments.
Ask your doctor or nurse whether abiraterone is suitable for you. You can also speak to our Specialist Nurses.